Granted Patent
B2
US 7,053,180 · App. 10/459,190 · Granted May 30, 2006
Isolated islet beta-cell two-pore domain potassium channel
Assignee:
Metabolex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides polynucleotides encoding potassium channels as well as methods of using the potassium channels to treat and diagnose diabetes and a predisposition for diabetes.
Claims (1)
1. An isolated or purified polypeptide comprising SEQ ID NO:2.
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded Aug 7, 2015
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036307/0406 →
SECURITY AGREEMENT
Recorded Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →
CHANGE OF NAME
Recorded Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031516/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 23, 2004
From: JOHNSON, JEFFREY D.; SCHWEITZER, ANTHONY C.; PALMA, JOHN F.; BLUME, JOHN E.
To: METABOLEX, INC.
Reel/Frame 015485/0864 →
Continuity (2)
Provisional Application
6038764200
· Jun 10, 2002